Skip to content

Genicular nerve radiofrequency ablation with and without Duloxetine in chronic knee osteoarthritis

Comparison of quality of life in patients treated with genicular nerve radiofrequency ablation with and without duloxetine in chronic knee osteoarthritis: A Prospective Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/02/023270
Enrollment
92
Registered
2020-02-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

Intervention1: patients recieving Genicular Nerve Radiofrequency Ablation with Duloxetine 60 mg HS: Patients will be receiving duloxetine 60 mg HS with genicular nerve block Control Intervention1: pat

Sponsors

AIIMS Jodhpur Research Committee
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with diagnosis of radiologically verified grade III or IV osteoarthritis according to the Kellgren-Lawrence Grading Scale who are not willing or not fit for knee replacement due to concomitant comorbid medical diseases

Exclusion criteria

Exclusion criteria: Multiple joint involvement, History of knee surgery Experiencing acute knee pain with inflammation findings Connective tissue disease affecting the knee joint Serious psychiatric disorder or neurological disease Sciatica Current use of anticoagulant drugs Having received intra-articular steroid or hyaluronic acid injection within the previous 3 months. Patient not willing to participate in study Allergy to duloxetine.

Design outcomes

Primary

MeasureTime frame
Comparison in improvement of quality of Life by WOMAC score in both groups.Timepoint: 2 weeks, 1 month, 2 months and 3 months

Secondary

MeasureTime frame
1. Comparison of NRS score in both group 2. Total analgesic consumption in both groups 3. Patient satisfaction in both groups 4. To note the associated complications/ side effects of study drug- abnormal proprioception, numbness, paraesthesia, neuralgia, and motor weakness, nausea, constipation and loss of appetite. Timepoint: 2 weeks, 1 month, 2 months and 3 months

Countries

India

Contacts

Public ContactSOMYA GOEL

AIIMS Jodhpur

geetamanoj007@yahoo.co.in941084584

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026